These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
286 related articles for article (PubMed ID: 9989833)
1. Constitutive activation of the 41-/43-kDa mitogen-activated protein kinase signaling pathway in human tumors. Hoshino R; Chatani Y; Yamori T; Tsuruo T; Oka H; Yoshida O; Shimada Y; Ari-i S; Wada H; Fujimoto J; Kohno M Oncogene; 1999 Jan; 18(3):813-22. PubMed ID: 9989833 [TBL] [Abstract][Full Text] [Related]
2. Constitutive activation of mitogen-activated protein (MAP) kinases in human renal cell carcinoma. Oka H; Chatani Y; Hoshino R; Ogawa O; Kakehi Y; Terachi T; Okada Y; Kawaichi M; Kohno M; Yoshida O Cancer Res; 1995 Sep; 55(18):4182-7. PubMed ID: 7664295 [TBL] [Abstract][Full Text] [Related]
3. Activation of the 41/43 kDa mitogen-activated protein kinase signaling pathway is required for hepatocyte growth factor-induced cell scattering. Tanimura S; Chatani Y; Hoshino R; Sato M; Watanabe S; Kataoka T; Nakamura T; Kohno M Oncogene; 1998 Jul; 17(1):57-65. PubMed ID: 9671314 [TBL] [Abstract][Full Text] [Related]
4. Changes in androgen receptor nongenotropic signaling correlate with transition of LNCaP cells to androgen independence. Unni E; Sun S; Nan B; McPhaul MJ; Cheskis B; Mancini MA; Marcelli M Cancer Res; 2004 Oct; 64(19):7156-68. PubMed ID: 15466214 [TBL] [Abstract][Full Text] [Related]
5. Constitutive activation of the 41- and 43-kDa mitogen-activated protein (MAP) kinases in the progression of prostate cancer to an androgen-independent state. Oka H; Chatani Y; Kohno M; Kawakita M; Ogawa O Int J Urol; 2005 Oct; 12(10):899-905. PubMed ID: 16323984 [TBL] [Abstract][Full Text] [Related]
6. Signal transduction pathways activated and required for mammary carcinogenesis in response to specific oncogenes. Amundadottir LT; Leder P Oncogene; 1998 Feb; 16(6):737-46. PubMed ID: 9488037 [TBL] [Abstract][Full Text] [Related]
7. Regulation of the MAP kinase cascade. Cobb MH; Xu S; Hepler JE; Hutchison M; Frost J; Robbins DJ Cell Mol Biol Res; 1994; 40(3):253-6. PubMed ID: 7874203 [TBL] [Abstract][Full Text] [Related]
8. A dominant role for the c-Jun NH2-terminal kinase in oncogenic ras-induced morphologic transformation of human lung carcinoma cells. Xiao L; Lang W Cancer Res; 2000 Jan; 60(2):400-8. PubMed ID: 10667594 [TBL] [Abstract][Full Text] [Related]
9. Genomic loci of human mitogen-activated protein kinases. Li L; Wysk M; Gonzalez FA; Davis RJ Oncogene; 1994 Feb; 9(2):647-9. PubMed ID: 8290275 [TBL] [Abstract][Full Text] [Related]
10. Activation of the RAF/mitogen-activated protein/extracellular signal-regulated kinase kinase/extracellular signal-regulated kinase pathway mediates apoptosis induced by chelerythrine in osteosarcoma. Yang R; Piperdi S; Gorlick R Clin Cancer Res; 2008 Oct; 14(20):6396-404. PubMed ID: 18927278 [TBL] [Abstract][Full Text] [Related]
11. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB. Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544 [TBL] [Abstract][Full Text] [Related]
12. Role of p38 mitogen-activated protein kinase and extracellular signal-regulated protein kinase kinase in adenosine A2B receptor-mediated interleukin-8 production in human mast cells. Feoktistov I; Goldstein AE; Biaggioni I Mol Pharmacol; 1999 Apr; 55(4):726-34. PubMed ID: 10101031 [TBL] [Abstract][Full Text] [Related]
13. Cloning of DPK, a novel dendritic cell-derived protein kinase activating the ERK1/ERK2 and JNK/SAPK pathways. Zhang W; Chen T; Wan T; He L; Li N; Yuan Z; Cao X Biochem Biophys Res Commun; 2000 Aug; 274(3):872-9. PubMed ID: 10924369 [TBL] [Abstract][Full Text] [Related]
14. Activation of Raf-1 in human pancreatic adenocarcinoma. Berger DH; Jardines LA; Chang H; Ruggeri B J Surg Res; 1997 Apr; 69(1):199-204. PubMed ID: 9202670 [TBL] [Abstract][Full Text] [Related]
15. Lack of constitutive activation of MAP kinase pathway in human acute myeloid leukemia cells with N-Ras mutation. Iida M; Towatari M; Nakao A; Iida H; Kiyoi H; Nakano Y; Tanimoto M; Saito H; Naoe T Leukemia; 1999 Apr; 13(4):585-9. PubMed ID: 10214865 [TBL] [Abstract][Full Text] [Related]
16. p67/MetAP2 suppresses K-RasV12-mediated transformation of NIH3T3 mouse fibroblasts in culture and in athymic mice. Majumdar A; Ghosh A; Datta S; Prudner BC; Datta B Biochemistry; 2010 Nov; 49(47):10146-57. PubMed ID: 21033716 [TBL] [Abstract][Full Text] [Related]
17. Lack of elevated MAP kinase (Erk) activity in pancreatic carcinomas despite oncogenic K-ras expression. Yip-Schneider MT; Lin A; Barnard D; Sweeney CJ; Marshall MS Int J Oncol; 1999 Aug; 15(2):271-9. PubMed ID: 10402237 [TBL] [Abstract][Full Text] [Related]
18. MAP kinases: activation, subcellular localization and role in the control of cell proliferation. Lenormand P; Pagès G; Sardet C; L'Allemain G; Meloche S; Pouysségur J Adv Second Messenger Phosphoprotein Res; 1993; 28():237-44. PubMed ID: 8398409 [No Abstract] [Full Text] [Related]
19. Increasing complexity of Ras signaling. Campbell SL; Khosravi-Far R; Rossman KL; Clark GJ; Der CJ Oncogene; 1998 Sep; 17(11 Reviews):1395-413. PubMed ID: 9779987 [TBL] [Abstract][Full Text] [Related]
20. Prolactin stimulates mitogen-activated protein kinase in human leiomyoma cells. Nohara A; Ohmichi M; Koike K; Jikihara H; Kimura A; Masuhara K; Ikegami H; Inoue M; Miyake A; Murata Y Biochem Biophys Res Commun; 1997 Sep; 238(2):473-7. PubMed ID: 9299534 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]